Heart Health
Why Fenofibrate Outperforms Other Fibrates for Cardiovascular Risk
Not all fibrates work the same way — fenofibrate uniquely reduces apoB, cutting residual cardiovascular risk beyond statins alone.
Research Paper
Jun 6, 2026 0
Results for "Fisetin" in Heart Disease
20 articles
Heart Health
Blocking Fat Production Enzyme Protects Hearts From Dangerous Enlargement
New research shows inhibiting fatty acid synthase prevents cardiac hypertrophy and restores heart function in multiple models.
Research Paper
Apr 2, 2026 0
Heart Health
Heart Drug Finerenone Shows Promise for Preventing Dangerous Irregular Heartbeat
New research reveals finerenone may reduce new-onset atrial fibrillation in heart failure patients with preserved ejection fraction.
Research Paper
Mar 28, 2026 1
Heart Health
Premium
Vascular Rejuvenation: Advanced Interventions to Reverse Arterial Aging
Dive deep into the molecular mechanisms of vascular aging and explore cutting-edge interventions — from senolytic therapies and nitric oxide restoration to exercise-induced remodeling and emerging pharmacological approaches — that are redefining what's possible in cardiovascular longevity.
TutorialAdvanced
May 2, 2026 0
Heart Health
SIRT5 Blocks Cardiac Fibrosis by Rewiring Fibroblast Metabolism
A sirtuin enzyme prevents heart scarring by keeping cardiac fibroblasts from switching to a pro-fibrotic metabolic state.
Research Paper
Apr 24, 2026 0
Heart Health
Plant Compound Tectorigenin Protects Heart from Hypertrophy by Stabilizing Mitochondria
Natural isoflavone prevents cardiac enlargement through novel mitochondrial protection pathway, offering new therapeutic approach.
Research Paper
Apr 3, 2026 0
Heart Health
Tirzepatide Delivers Sweeping Cardiometabolic Benefits Beyond Weight Loss
A comprehensive review reveals tirzepatide improves blood pressure, lipids, liver fat, kidney function, and slashes 10-year cardiovascular risk by up to 23.5%.
Research Paper
May 30, 2026 0
Heart Health
New Drug Sotatercept Shows Promise for Heart Failure with Preserved Ejection Fraction
Sotatercept emerges as potential treatment for combined pre-capillary pulmonary hypertension and heart failure with preserved ejection fraction.
Research Paper
Mar 30, 2026 0
Heart Health
Flavonoid Isoquercitrin Fights Atherosclerosis Through Gut Microbiome Axis
Isoquercitrin reshapes gut bacteria and tryptophan metabolism to reduce arterial plaque, pointing to a novel gut-heart therapeutic pathway.
Research Paper
Apr 24, 2026 0
Heart Health
New FDA-Approved COPD Drug Ensifentrine Shows Promise in Major Clinical Trials
First new COPD medication in over a decade targets dual pathways to improve breathing and reduce inflammation.
Video
Mar 29, 2026 7
Heart Health
GDF11 Protein Blocks Artery Calcification by Reducing Inflammation
New research shows GDF11, an anti-aging protein, prevents dangerous calcium buildup in arteries by suppressing inflammatory pathways.
Research Paper
Apr 5, 2026 0
Heart Health
Sirtuins May Hold the Key to Stopping Heart Failure's Silent Scarring
A new review reveals how sirtuin enzymes regulate cardiac fibrosis and why targeting them could reshape heart failure treatment.
Research Paper
May 7, 2026 0
Heart Health
Elamipretide Wins First FDA Approval for Barth Syndrome Via Mitochondrial Repair
The first disease-specific treatment for Barth syndrome gains FDA accelerated approval, targeting mitochondrial dysfunction to restore muscle strength.
Research Paper
May 20, 2026 0
Heart Health
Senolytic Drug Navitoclax Reduces Heart Failure Symptoms and Cardiac Fibrosis
New study shows clearing senescent cells with Navitoclax improves heart function and reduces inflammation in heart failure with preserved ejection fraction.
Research Paper
Apr 4, 2026 0
Heart Health
Bempedoic Acid Plus Ezetimibe Combo Targets LDL in Diabetic Patients
A Phase 2 trial tests whether a fixed-dose combination pill can safely lower LDL cholesterol in people with type 2 diabetes.
Clinical Trial
Jun 17, 2026 0
Heart Health
Anacetrapib Added to Statins Tested for Cholesterol Control in Phase 3 Trial
Merck's CETP inhibitor anacetrapib was evaluated alongside statin therapy to assess LDL-C lowering and HDL-C raising in hypercholesterolemia patients.
Clinical Trial
Jun 15, 2026 0
Heart Health
Phase 3 Trial Tests Tafamidis for TTR Amyloid Heart Disease
Pfizer's landmark trial examines whether tafamidis can safely treat transthyretin amyloid cardiomyopathy, a progressive and often fatal heart condition.
Clinical Trial
Jun 13, 2026 0
Heart Health
Tirzepatide Outperforms Dulaglutide for Heart and Kidney Protection in Diabetes
Major study shows tirzepatide reduces cardiovascular and kidney complications by 16% compared to dulaglutide in diabetic patients.
Research Paper
Mar 30, 2026 0
Heart Health
SGLT2 Inhibitors Cut Death and Heart Failure Risk Even in Patients Over 80
Real-world study of 1,559 octogenarians finds SGLT2 inhibitors reduce all-cause death by 42% and heart failure rehospitalization by 31% with no increase in adverse events.
Research Paper
May 12, 2026 0
Heart Health
Bariatric Surgeon Who Lost 50 Pounds on Tirzepatide Defends Statins and GLP-1s
Dr. Terry Simpson brings personal experience with FH, tirzepatide, and statins to a blunt takedown of health misinformation.
Podcast
Jun 2, 2026 0
Heart Health
New Cholesterol Drugs Show Promise for Children with Genetic High Cholesterol
Advanced therapies like PCSK9 and ANGPTL3 inhibitors offer hope for kids with familial hypercholesterolemia when statins aren't enough.
Research Paper
Mar 28, 2026 1
Page 1 of 2Next